Erik Obitz
Impact in
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
- Dermatology and Skin Diseases
-
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
Papers in
-
- Cutaneous lymphoproliferative disorders research 2
- Dermatology and Skin Diseases 1
-
- Autoimmune Bullous Skin Diseases 1
- Lymphoma Diagnosis and Treatment 1
- Co-authors
- Ole Baadsgaard (2 shared papers)Steen Lisby (1 shared paper)Anders Österborg (1 shared paper)Thomas Schwarz (1 shared paper)Roland Kaufmann (1 shared paper)Youn H. Kim (1 shared paper)Tim Illidge (2 shared papers)Susan Jane Knox (2 shared papers)
- Journals
- Blood (1 paper)British Journal of Dermatology (1 paper)Journal of Investigative Dermatology (1 paper)Frontiers in Medicine (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- DenmarkUnited KingdomGermany
In The Last Decade
Erik Obitz
6 papers receiving 218 citations
Peers
Comparison fields: 5 of 27
- Dermatology 102
- Immunology 47
- Pathology and Forensic Medicine 40
- Virology 7
- Radiology, Nuclear Medicine and Imaging 27
Countries citing papers authored by Erik Obitz
This map shows the geographic impact of Erik Obitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Obitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Obitz more than expected).
Fields of papers citing papers by Erik Obitz
This network shows the impact of papers produced by Erik Obitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Obitz. The network helps show where Erik Obitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Obitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 144 | |
| 2 | 2003 | 51 | |
| 3 | 2014 | 25 | |
| 4 | 2004 | 10 | |
| 5 | 2009 | 5 | |
| 6 | HuMax-CD4, fully human monoclonal antibody: Phase II trial in cutaneous T cell lymphoma | 2004 | 2 |
About Erik Obitz
Erik Obitz is a scholar working on Dermatology, Pathology and Forensic Medicine, Parasitology, Immunology and Nuclear Energy and Engineering, having authored 6 papers that have together received 237 indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (2 papers), Vector-borne infectious diseases (1 paper), Dermatology and Skin Diseases (1 paper), Autoimmune Bullous Skin Diseases (1 paper), Psoriasis: Treatment and Pathogenesis (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Dermatology (102 citations), Immunology (47 citations), Pathology and Forensic Medicine (40 citations), Virology (7 citations) and Radiology, Nuclear Medicine and Imaging (27 citations). Erik Obitz has collaborated with scholars based in Denmark, United Kingdom and Germany. Frequent co-authors include Ole Baadsgaard, Steen Lisby, Anders Österborg, Thomas Schwarz, Roland Kaufmann, Youn H. Kim, Tim Illidge, Susan Jane Knox, Kevin D. Cooper and Kim Mark Knudsen. Their work appears in journals such as Blood, British Journal of Dermatology, Journal of Investigative Dermatology, Frontiers in Medicine and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.